People: Novo Nordisk A/S (NOVOb.CO)
16 Aug 2019
Dr. Martin Mackay, Ph.D. has been Independent Director of NOVO NORDISK A/S since March 22, 2018. He is Chairman of the Research & Development Committee. He co-founded Rallybio LLC, US, in January 2018 and serves as chair of the board and in an executive leadership role overseeing all research and non-research functions. He is Senior Advisor to New Leaf Venture Partners, LLC, US and Member of the board of Charles River Laboratories International, Inc., US. He holds Doctorate/PhD from University of Edinburgh, UK (1984), BSc (First Class Honours) in Microbiology from Heriot-Watt University, Edinburgh, UK (1979).
|Total Annual Compensation, DKK||1,200,000|
|Restricted Stock Awards, DKK||--|
|Long-Term Incentive Plans, DKK||--|
|All Other, DKK||--|
|Fiscal Year Total, DKK||1,200,000|